α-Amylase-IN-14

α-Amylase-IN-14, a derivative of Nicotinic (HY-B0143), is an α-amylase inhibitor and has good interactions with α-amylase protein (-5.55 kcal/mol) . α-Amylase-IN-14 is a dual anti-inflammatory and anti-hyperglycemic agent. α-Amylase-IN-14 exhibits good results against DPPH and ABTS radicals. α-Amylase-IN-14 can be used for the study of diabetes[1].

Product Specifications

CAS Number

[1099611-82-1]

UNSPSC

12352005

Target

Amylases; Reactive Oxygen Species (ROS)

Related Pathways

Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB

Field of Research

Metabolic Disease; Inflammation/Immunology

Smiles

O=C(C1=CC=CN=C1)OC2=CC=C3OCOC3=C2

Molecular Formula

C13H9NO4

Molecular Weight

243.21

References & Citations

[1]Ramakrishnan K, et al. Discovery of new pyridine 3-carboxylic acid-based pharmacophores as dual anti-inflammatory and anti-hyperglycemic agents. Sci Rep. 2025 Oct 3;15 (1) :34536.